BML Capital Management, LLC 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
BML Capital Management, LLC disclosed 18 US equity positions worth $108.7m in its Q3 2025 13F filing. The largest position was ACRS at 24.9% of the reported book, followed by AVIR and AVU0. Against the Q2 2025 filing, it opened 6 new positions, added to 4 and reduced 2 among the top 18 holdings.
What did BML Capital Management, LLC own in Q3 2025? Top 18 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 24.9% | $27.1m | 14,250,000 | 0% | held |
| 2 | AVIR ATEA PHARMACEUTICALS INC | Healthcare | 19.9% | $21.7m | 7,473,963 | -2% | reduced |
| 3 | AVU0 ADVERUM BIOTECHNOLOGIES INC | 12.7% | $13.9m | 3,057,526 | 0% | held | |
| 4 | TIL INSTIL BIO INC | 10.6% | $11.5m | 645,600 | 21% | added | |
| 5 | ORMP ORAMED PHARMACEUTICALS INC | 7.7% | $8.4m | 3,167,231 | 3% | added | |
| 6 | PMVP PMV PHARMACEUTICALS INC | 6.8% | $7.4m | 5,292,000 | 6% | added | |
| 7 | ALMS ALUMIS INC | 4.4% | $4.8m | 1,210,415 | 0% | held | |
| 8 | LAVA THERAPEUTICS NV | 2.8% | $3.1m | 1,970,610 | 0% | held | |
| 9 | 2KZ0 KEZAR LIFE SCIENCES INC | 2.6% | $2.8m | 720,787 | 13% | added | |
| 10 | CNTB CONNECT BIOPHARMA HLDGS LTD | 1.8% | $1.9m | 1,267,500 | – | new | |
| 11 | IMA IMAGENEBIO INC | 1.4% | $1.5m | 182,509 | – | new | |
| 12 | LONA ATHIRA PHARMA INC | 1.2% | $1.3m | 323,066 | – | new | |
| 13 | ASTROTECH CORP | 1.0% | $1.1m | 220,410 | 0% | held | |
| 14 | TGT TARGET CORP | Consumer Defensive | 0.8% | $897.0k | 10,000 | – | new |
| 15 | VTGN VISTAGEN THERAPEUTICS INC | 0.5% | $532.5k | 150,000 | 0% | held | |
| 16 | ARVN ARVINAS INC | Healthcare | 0.4% | $426.0k | 50,000 | – | new |
| 17 | LSTA LISATA THERAPEUTICS INC | 0.3% | $287.8k | 109,841 | -48% | reduced | |
| 18 | MURAL ONCOLOGY PUB LTD CO | 0.1% | $119.0k | 57,500 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.